XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Cash flows from operating activities    
Net income $ 459 $ 1,045
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 4,153 3,376
Equity based compensation 2,964 2,039
Tax benefit from exercise/vesting of equity awards 1,054 593
Deferred financing charges 119 304
Equity loss in joint venture 433 475
Changes in operating assets and liabilities:    
Accounts receivable, net (22,306) (33,200)
Inventories (82,868) (117,392)
Income taxes, net (6,680) (3,348)
Prepaid expenses and other current assets (12,547) (11,540)
Other assets, net (245) (153)
Accounts payable, accrued expenses and other liabilities 57,727 22,356
Net cash used in operating activities (57,737) (135,445)
Cash flows from investing activities    
Investment in equity of joint venture   (2,500)
Capital expenditures (4,518) (8,016)
Net cash used in investing activities (4,518) (10,516)
Cash flows from financing activities    
Proceeds from notes payable, net 56,957 141,974
Proceeds from noncontrolling interest investment 1,715  
Proceeds from exercise of equity awards 269 493
Excess tax benefit from exercise/vesting of equity awards 1,362 2,049
Net cash provided by financing activities 60,303 144,516
Effect of exchange rate changes (55) (34)
Net decrease in cash and cash equivalents (2,007) (1,479)
Cash and cash equivalents at beginning of period 24,660 10,045
Cash and cash equivalents at end of period 22,653 8,566
Cash paid during the period for:    
Interest 1,902 1,191
Income taxes $ 4,438 $ 1,332